NEUROPATHY IMPAIRMENT AND NUTRITIONAL STATUS WITH EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS

被引:0
|
作者
Conceicao, Isabel [1 ]
Wixner, Jonas [2 ]
Berk, John [3 ]
Adams, David [4 ]
Polydefkis, Michael [5 ]
Attarian, Shahram [6 ]
Gillmore, Julian [7 ]
Dyck, P. James [8 ]
Coelho, Teresa [9 ,10 ]
Chen, Jersey [11 ]
Hardy, Elise [11 ]
Kwoh, Jesse [12 ]
Natman, Jonatan [13 ]
Cruz, Marcia Waddington [14 ]
机构
[1] Hosp Santa Maria, Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[2] Umea Univ, Umea, Sweden
[3] Boston Univ, Sch Med, Boston, MA USA
[4] Hop Bicetre, Le Kremlin Bicetre, France
[5] Johns Hopkins Univ, Baltimore, MD USA
[6] Ctr Hosp Univ La Timone, Neuromuscular Disorders & ALS Dept, Marseille, France
[7] UCL, Natl Amyloidosis Ctr, London, England
[8] Mayo Clin, Dept Neurol, Rochester, MN USA
[9] Ctr Hosp Univ Santo Antonio, Porto, Portugal
[10] ERN NMD, Paris, France
[11] AstraZeneca, Late Stage Dev Cardiovasc Renal & Metab, BioPharmaceut R&D, Gaithersburg, MD USA
[12] Ionis Pharmaceut Inc, Carlsbad, CA USA
[13] AstraZeneca, Global Evidence, BioPharmaceut Med, Gothenburg, Sweden
[14] Univ Fed Rio de Janeiro, Amyloidosis Ctr, CEPARM, Univ Hosp, Rio De Janeiro, Brazil
关键词
Amyloid; ATTRv; eplontersen; polyneuropathy; transthyretin amyloidosis;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P 319
引用
收藏
页码:S138 / S138
页数:1
相关论文
共 50 条
  • [1] Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis
    Wixner, Jonas
    Conceicao, Isabel
    Berk, John
    Adams, David
    Polydefkis, Michael
    Shahram, Attarian
    Gillmore, Julian D.
    Dyck, P. James B.
    Coelho, Teresa
    Chen, Jersey
    Hardy, Elise
    Kwoh, Jesse
    Natman, Jonatan
    Cruz, Marcia Waddington
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S68 - S68
  • [2] Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis
    Anwar, Insa Binte
    Ahmed, Iqra Furqan
    Mahmood, Fariha
    Haseeb, Abdul
    Ahmed, Khabab Abbasher Hussien Mohamed
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (01): : 20 - 23
  • [3] A mini-review of Vutrisiran and Eplontersen in hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Olatunji, Gbolahan
    Kokori, Emmanuel
    Abraham, Israel Charles
    Omoworare, Oluwatobi
    Olatunji, Doyin
    Ezeano, Chimezirim
    Emmanuel Adeoba, Babawale
    Stanley, Anthony Chidera
    Oluwatobiloba, Awoyinfa Michael
    Oluwademilade, Omidiran Basit
    Shimelis, Kale Mekoya
    Olanisa, Olawale
    Aderinto, Nicholas
    MEDICINE, 2024, 103 (26) : e38767
  • [4] Impact of Patisiran, an investigational RNAi Therapeutic, on nutritional status in patients with hereditary Transthyretin-Mediated Amyloidosis
    Obici, L.
    Coelho, T.
    Adams, D.
    Gonzalez-Duarte, A.
    O'Riordan, W.
    Yang, C-C.
    Yamashita, T.
    Kristen, A.
    Tournev, I.
    Schmidt, H.
    Berk, J.
    Lin, K-P.
    Gandhi, P.
    Sweetser, M.
    Chen, J.
    Goyal, S.
    Gollob, J.
    Suhr, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 17 - 17
  • [5] Patisiran in hereditary transthyretin-mediated amyloidosis
    Luigetti, Marco
    Servidei, Serenella
    LANCET NEUROLOGY, 2021, 20 (01): : 21 - 23
  • [6] Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trial
    Wixner, Jonas
    Berk, John L.
    Adams, David
    Polydefkis, Michael
    Conceicao, Isabel
    Attarian, Shahram
    Gillmore, Julian D.
    Dyck, P. James B.
    Folkvaljon, Folke
    Zhou, Wunan
    Chen, Jersey
    Viney, Nicholas J.
    Kwoh, T. Jesse
    Coelho, Teresa
    Waddington-Cruz, Marcia
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2025, 32 (01): : 29 - 38
  • [7] Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Karam, Chafic
    Gillmore, Julian
    Chen, Gengshi
    Jenkins, Nia
    Hale, Mike
    Taylor, Gemma
    Chen, Jersey
    Viney, Nicholas
    Schneider, Eugene
    NEUROLOGY, 2023, 100 (17)
  • [8] Hereditary transthyretin-mediated amyloidosis masquerading as diabetic neuropathy and lumbar radiculopathy
    Horiuchi, Kohei
    Hortelano, Chiara
    Nikfar, Reza
    Fogel, Joyce
    BMJ CASE REPORTS, 2024, 17 (09)
  • [9] Hereditary Transthyretin-mediated Amyloidosis Masquerading as Diabetic Neuropathy and Lumbar Radiculopathy
    Horiuchi, K.
    Hortelano, C.
    Fogel, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S187 - S187
  • [10] Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
    Conceicao, Isabel
    Berk, John L.
    Weiler, Markus
    Kowacs, Pedro A.
    Dasgupta, Noel R.
    Khella, Sami
    Chao, Chi-Chao
    Attarian, Shahram
    Kwoh, T. Jesse
    Jung, Shiangtung W.
    Chen, Jersey
    Viney, Nicholas J.
    Yu, Rosie Z.
    Gertz, Morie
    Masri, Ahmad
    Cruz, Marcia Waddington
    Coelho, Teresa
    JOURNAL OF NEUROLOGY, 2024, 271 (10) : 6655 - 6666